8-KItem 5.02 · Officer/Director Change
AbbVie Adds John Carethers as Independent Director
Filed with the SEC on · Summarized by InvestorsBot
AbbVie expanded its board from 12 to 13 members on October 14, 2026, appointing Dr. John M. Carethers as a Class II independent director. Carethers, vice chancellor for health sciences at the University of California San Diego and a former Avantor director, will serve on AbbVie’s Public Policy and Sustainability Committee and receive the company’s standard independent-director compensation.